Industry Voices

Today we introduce another name to our list of Industry Voices editors. Rhonda Greenapple is the president and founder of Reimbursement Intelligence, a consulting firm serving early stage biotech and the investment community. Before founding the group, Rhonda built a nationally recognized leadership team as President of the Managed Markets division of McCann Healthcare. Her experience includes the managed care and reimbursement execution from blockbusters to orphan drugs

For more information about the survey discussed in this article or to receive the RI Monitor Newsletter, visit

Suggested Articles

Imbruvica has enjoyed a nice run in previously untreated CLL over the last few years. But major competition is here in the form of AZ's Calquence.

Pennsylvania's Supreme Court revived thousands of lawsuits alleging the antipsychotic med Risperdal caused males to develop breasts.

In the asthma biologics race, there doesn't appear to be a clear favorite among Xolair, Dupixent, Fasenra and Nucala for a group of pulmonologists.